RHI Magnesita (RHIM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Mar, 2026Executive summary
Delivered full-year profit guidance in 2025 through structural, cost-based self-help initiatives, despite unprecedented market challenges and no visible market recovery, with strong H2 recovery driven by internal measures.
Revenue declined 3% year-over-year to €3.37bn, with gross profit down 10% and adjusted EBITA down 8%.
Strategic focus on operational discipline, safety, sustainability, and local-for-local production, with significant progress in safety culture and CO2 intensity reduction.
Strategic acquisition of Resco transformed North American footprint, increased US local production, and contributed to earnings.
No expectation of market recovery before 2027; guidance for 2026 is based on controllable factors.
Financial highlights
Revenue: €3.37bn (-3% YoY); Adjusted EBITDA declined to EUR 373 million in 2025 from EUR 407 million in 2024, with a margin of 11.1%.
Operating cash flow was EUR 391 million, with cash conversion over 100% and free cash flow of EUR 214 million.
Net debt increased to EUR 1.5 billion due to the Resco acquisition; leverage at 2.9x net debt to EBITDA.
Final dividend of EUR 1.20 per share, full-year dividend EUR 1.80, in line with 2024.
Working capital intensity improved to 21.7%, with ~€90m released via improved inventory and AR management.
Outlook and guidance
2026 adjusted EBITDA/EBITA guidance: EUR 435 million constant currency, EUR 400 million reported, margin ~11.5%.
No demand improvement expected in steel; gradual improvement in industrial business anticipated, especially in H2 2026.
Currency headwinds expected to negatively impact earnings by EUR 35 million in 2026.
Deleveraging target of 2.6x by end 2026, with strong cash generation supporting balance sheet.
No meaningful cash outflows for M&A expected in 2026; focus on future opportunities.
Latest events from RHI Magnesita
- Stable revenue and strong cash flow; EBITA guidance reaffirmed despite weak demand.RHIM
H1 20243 Feb 2026 - Margins exceeded guidance despite weak demand; EBITA outlook trimmed amid persistent overcapacity.RHIM
Q3 2024 TU15 Jan 2026 - Solid 2024 results and margin gains despite weak demand; modest growth seen for 2025.RHIM
H2 202416 Dec 2025 - Weak Q1, overcapacity, and trade risks make H2 recovery vital for guidance.RHIM
Q1 2025 TU21 Nov 2025 - Revenue and margins fell on weak demand and pricing, but H2 recovery is expected.RHIM
H1 202516 Nov 2025 - Cost savings and RESCO integration drove margin recovery despite weak demand.RHIM
Q3 2025 TU10 Nov 2025